Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas

Stem Cell Research & Therapy
Qing ZhangPeng Fu

Abstract

Glioma, which accounts for more than 30% of primary central nervous system tumours, is characterised by symptoms such as headaches, epilepsy, and blurred vision. Glioblastoma multiforme is the most aggressive, malignant, and lethal brain tumour in adults. Even with progressive combination treatment with surgery, radiotherapy, and chemotherapy, the prognosis for glioma patients is still extremely poor. Compared with the poor outcome and slowly developing technologies for surgery and radiotherapy, the application of targeted chemotherapy with a new mechanism has become a research focus in this field.Moreover, targeted therapy is promising for most solid tumours. The tumour-tropic ability of stem cells, including neural stem cells and mesenchymal stem cells, provides an alternative therapeutic approach. Thus, mesenchymal stem cell-based therapy is based on a tumour-selective capacity and has been thought to be an effective anti-tumour option over the past decades. An increasing number of basic studies on mesenchymal stem cell-based therapy for gliomas has yielded complex outcomes.In this review, we summarise the biological characteristics of human mesenchymal stem cells, and the current status and potential challenges of mesenchym...Continue Reading

References

Jun 11, 1998·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·S P BruderS Kadiyala
Sep 25, 1998·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·R G YoungD J Fink
Jan 19, 1999·Journal of Neuro-oncology·T S SurawiczH R Menck
Apr 2, 1999·Science·M F PittengerD R Marshak
May 13, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J E DennisA I Caplan
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·K S AboodyE Y Snyder
Sep 19, 2003·Nature·Philip N Benfey
Apr 27, 2004·Oncogene·Nedime SerakinciMoustapha Kassem
Sep 21, 2004·World Journal of Gastroenterology : WJG·Li-Bo ChenLian Yang
Nov 10, 2004·Medical Hypotheses·Jian-Guo RenConover Talbot
Nov 25, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kuan-Der LeeOscar Kuang-Sheng Lee
Nov 30, 2004·Science·Jeanmarie HoughtonTimothy C Wang
Dec 8, 2004·Best Practice & Research. Clinical Obstetrics & Gynaecology·Ian Rogers, Robert F Casper
Feb 1, 2005·The American Journal of Pathology·Benedetta BussolatiGiovanni Camussi
Apr 19, 2005·Cancer Research·Akira NakamizoFrederick F Lang
Apr 19, 2005·Biotechnology Letters·Tao ZhangYuan Lu
Aug 26, 2006·Nature Clinical Practice. Neurology·Judith A SchwartzbaumMargaret Wrensch
May 28, 2008·Injury·Karoliina PelttariWiltrud Richter
Sep 12, 2008·Proceedings of the National Academy of Sciences of the United States of America·Zhaoyong LiGary S Stein
Jan 13, 2009·Gene·Ling LingSimon M Cool
Mar 11, 2009·The Journal of Gene Medicine·Ryosuke UchiboriKeiya Ozawa
Sep 22, 2009·Cancer Letters·Miroslava MatuskovaLucia Kucerova
Nov 26, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Masato Yamamoto, David T Curiel
Jun 15, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Seung Ah ChoiSeung-Ki Kim
Dec 14, 2011·The International Journal of Artificial Organs·Elisa FiorentiniGabriela Ciapetti
Jan 11, 2012·Experimental Neurology·Christian SchichorJoerg-Christian Tonn
May 15, 2012·The Lancet Oncology·Wolfgang WickUNKNOWN NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society
Aug 25, 2012·Bioscience Reports·Qiaoshu WangTao Zhang
Mar 30, 2013·Trends in Molecular Medicine·M Sarah S BovenbergBakhos A Tannous

❮ Previous
Next ❯

Citations

Nov 18, 2018·Journal of Cellular Biochemistry·Jun-Feng Huo, Xiao-Bing Chen
Oct 18, 2018·Clinical and Translational Medicine·Debarati GhoshSonali Bhattacharjee
Feb 23, 2020·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R C Da-CostaB E Strauss
Jul 12, 2019·Frontiers in Neurology·Mirja KrauseRebecca Lim
Jul 10, 2019·World Neurosurgery·Neil D AlmeidaJonathan H Sherman
Dec 22, 2020·Trends in Pharmacological Sciences·Lucas M BushTara L Deans
Dec 29, 2020·Frontiers in Bioengineering and Biotechnology·Henry Ruiz-GarciaDaniel M Trifiletti
Jan 20, 2021·ACS Biomaterials Science & Engineering·Kathryn M MooreKristy M Ainslie
Dec 24, 2021·Advanced Biology·Sirine Yassine, Nada Alaaeddine

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Related Papers

Cancer Treatment Reviews
Daniel BexellJohan Bengzon
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Cristóbal Belda-IniestaRosario Perona
Expert Opinion on Biological Therapy
A Jorge A TerzisRolf Bjerkvig
American Journal of Cancer Research
Priya U KumthekarSamir V Sejpal
Critical Reviews in Oncology/hematology
Michele ReniCharles J Vecht
© 2022 Meta ULC. All rights reserved